Diversify Advisory Services LLC Makes New $629,000 Investment in Encompass Health Corporation $EHC

Diversify Advisory Services LLC bought a new position in Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 5,527 shares of the company’s stock, valued at approximately $629,000.

Other hedge funds also recently made changes to their positions in the company. Royal Bank of Canada raised its holdings in Encompass Health by 21.5% in the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after purchasing an additional 15,677 shares in the last quarter. Millennium Management LLC grew its position in shares of Encompass Health by 38.4% in the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after buying an additional 25,574 shares during the period. Caxton Associates LLP purchased a new stake in shares of Encompass Health in the 1st quarter worth about $259,000. Walleye Capital LLC increased its stake in shares of Encompass Health by 667.6% in the 2nd quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after acquiring an additional 7,671 shares in the last quarter. Finally, Gamco Investors INC. ET AL purchased a new position in Encompass Health during the 2nd quarter valued at about $588,000. 97.25% of the stock is currently owned by institutional investors.

Insider Activity

In other Encompass Health news, CEO Mark J. Tarr sold 173,148 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the transaction, the chief executive officer owned 267,814 shares in the company, valued at approximately $33,602,622.58. This represents a 39.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP John Patrick Darby sold 8,906 shares of the firm’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the sale, the executive vice president directly owned 75,041 shares in the company, valued at approximately $9,451,413.95. The trade was a 10.61% decrease in their position. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by company insiders.

Encompass Health Price Performance

Shares of NYSE EHC opened at $120.89 on Friday. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The firm has a market cap of $11.93 billion, a P/E ratio of 19.69, a PEG ratio of 2.47 and a beta of 0.72. The company has a 50 day moving average of $110.63 and a 200 day moving average of $106.29. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.48 by $0.07. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company’s revenue was up 9.6% compared to the same quarter last year. During the same period last year, the business posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, research analysts expect that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. Encompass Health’s payout ratio is 12.38%.

Analysts Set New Price Targets

Several research firms recently commented on EHC. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, August 16th. UBS Group raised their target price on shares of Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research note on Friday, August 7th. TD Cowen lifted their target price on shares of Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a report on Monday, August 10th. Leerink Partners set a $152.00 price target on Encompass Health in a research report on Friday, May 22nd. Finally, Barclays upped their price target on Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $148.71.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.